In the spotlight: Nestle's Pfizer buy offers long-term baby food boost
Nestle has won through in the battle to acquire Pfizer's baby food business, securing an US$11.85bn deal that will see the world's largest infant nutrition group extend its lead in this fast-growing category. However, with a hefty price tag attached, the deal has not been warmly welcomed by investors. Katy Askew reports.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 15 years of archives.
I am so confident you will love complete access to our content that today I can offer you 30 days access for $1.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- Why Heinz-Kraft merger could herald more deals
- The challenges awaiting ConAgra's new CEO
- Focus: Can Mars gain share in Indian chocolate?
- Analysis: Is Heinz, Kraft merger "a growth story"?
- Interview: FrieslandCampina eyes Gulf expansion
- Mondelez coy on Philadelphia sale rumours
- Fatal explosion at French desserts firm Senagral
- Aryzta buys 49% of French retailer Picard
- Infographic: Heinz, Kraft unveil combined business
- Buffett: Kraft Heinz to withstand health focus